S Matthijs Boekholdt Selected Research

lipoprotein cholesterol

1/2018	Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
11/2016	Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population.
12/2015	Non-high-density lipoprotein cholesterol: current status as cardiovascular marker.
10/2007	Apolipoprotein A-II is inversely associated with risk of future coronary artery disease.
4/2005	Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Matthijs Boekholdt Research Topics

Disease

53	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 12/2002
37	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2003
25	Coronary Disease (Coronary Heart Disease) 01/2018 - 01/2007
16	Neoplasms (Cancer) 03/2020 - 09/2004
14	Atherosclerosis 11/2021 - 10/2003
14	Stroke (Strokes) 01/2019 - 09/2004
13	Myocardial Infarction 11/2020 - 12/2002
11	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 09/2013
7	Inflammation (Inflammations) 01/2022 - 03/2005
6	Hypertension (High Blood Pressure) 01/2022 - 04/2005
6	Diabetes Mellitus 01/2018 - 10/2007
5	Heart Failure 02/2020 - 11/2012
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2011 - 01/2009
4	Hypotension (Low Blood Pressure) 11/2016 - 04/2005
4	Type 2 Diabetes Mellitus (MODY) 01/2016 - 08/2011
3	Ischemic Stroke 11/2021 - 12/2020
3	Thrombosis (Thrombus) 01/2021 - 11/2002
3	Bicuspid Aortic Valve Disease 04/2019 - 09/2013
3	Peripheral Arterial Disease 03/2015 - 12/2012
3	Unstable Angina 04/2012 - 07/2010
3	Insulin Resistance 01/2012 - 01/2009
2	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 11/2013
2	Heart Diseases (Heart Disease) 01/2020 - 01/2020
2	Disease Progression 01/2019 - 01/2019
2	Heart Arrest (Cardiac Arrest) 01/2018 - 04/2012
2	Acute Coronary Syndrome 01/2017 - 11/2013
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2017 - 10/2005
2	Abdominal Obesity 04/2011 - 02/2011
2	Venous Thrombosis (Deep-Vein Thrombosis) 08/2010 - 11/2002
2	Atherosclerotic Plaque (Atheroma) 06/2010 - 08/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2008 - 10/2003
1	Ventricular Tachycardia 07/2022
1	Cognitive Dysfunction 01/2022
1	Necrosis 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Pericardial Effusion 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021
1	Myocarditis (Carditis) 01/2021
1	Wounds and Injuries (Trauma) 03/2020
1	Atrial Fibrillation 02/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	VLCAD deficiency 01/2020

Drug/Important Bio-Agent (IBA)

27	HDL CholesterolIBA 08/2017 - 08/2004
22	LipidsIBA 01/2020 - 10/2003
20	LDL CholesterolIBA 11/2021 - 08/2004
17	Lipoprotein(a)IBA 01/2022 - 06/2012
16	oxidized low density lipoproteinIBA 11/2021 - 10/2003
15	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2018 - 02/2008
14	C-Reactive ProteinIBA 01/2022 - 04/2005
13	Triglycerides (Triacylglycerol)IBA 05/2019 - 09/2006
13	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019 - 04/2005
12	Apolipoproteins B (ApoB)IBA 01/2019 - 10/2003
11	ApolipoproteinsIBA 01/2019 - 10/2003
11	CholesterolIBA 11/2016 - 05/2003
10	Lipoproteins (Lipoprotein)IBA 11/2018 - 04/2005
10	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017 - 10/2003
9	Atorvastatin (Lipitor)FDA Link 01/2018 - 08/2011
8	Secretory Phospholipases A2IBA 11/2021 - 04/2005
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2010
5	lipoprotein cholesterolIBA 01/2018 - 04/2005
5	Cholesterol Ester Transfer ProteinsIBA 01/2018 - 06/2003
5	Trinitrotoluene (TNT)IBA 01/2018 - 01/2013
4	CalciumIBA 09/2020 - 03/2013
4	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2020 - 06/2010
4	HDL LipoproteinsIBA 12/2010 - 08/2004
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2012
3	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2004
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021 - 07/2010
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2003
3	SubtilisinIBA 01/2018 - 01/2017
3	AdiponectinIBA 01/2012 - 02/2011
2	Apolipoprotein C-IIIIBA 11/2018 - 01/2017
2	EnzymesIBA 11/2018 - 04/2014
2	omega-Chloroacetophenone (Mace)IBA 01/2018 - 01/2018
2	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2017 - 01/2017
2	Pravastatin (Pravachol)FDA LinkGeneric 01/2016 - 05/2003
2	Simvastatin (Zocor)FDA LinkGeneric 03/2015 - 04/2014
2	IsoenzymesIBA 04/2014 - 11/2013
2	Phospholipases (Phospholipase)IBA 11/2013 - 06/2010
2	torcetrapibIBA 11/2012 - 08/2011
2	Immunoglobulin M (IgM)IBA 07/2012 - 10/2011
2	Interleukin-8 (Interleukin 8)IBA 07/2012 - 08/2004
2	Glucose (Dextrose)FDA LinkGeneric 08/2011 - 04/2011
2	Peroxidase (Myeloperoxidase)IBA 02/2011 - 07/2007
2	Apolipoprotein A-VIBA 05/2010 - 09/2006
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2022
1	PotassiumIBA 01/2022
1	SodiumIBA 01/2022
1	GadoliniumIBA 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 02/2020
1	Spironolactone (Aldactone)FDA LinkGeneric 02/2020
1	Carnitine palmitoyl transferase 2 deficiencyIBA 01/2020

Therapy/Procedure

17	Therapeutics 07/2022 - 11/2002
6	Secondary Prevention 01/2020 - 02/2008
2	Resuscitation 06/2013 - 04/2012
2	Stents 09/2010 - 03/2005
1	Arterial Switch Operation 01/2022
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2021
1	Radiotherapy 03/2020